London — A new nasal spray tested in trials could prevent the spread of COVID-19; at a biohazard clinic in the UK. Researchers at Raphael Labs spent a year testing the spray to stop and treat the virus and all of its strains.
The nasal spray works as a prophylactic and is a preventative medicine against the virus. pHOXWEL; as the spray is named, works in a completely different way to vaccines.
The spray is made of naturally virucidal plant compounds. However, the company is not releasing its list of ingredients until peer review and publication.
In the tests conducted, 13.1 percent of those receiving the spray tested positive for SARS-CoV-2; while 34.5 percent under placebo treatment tested positive.
Read more about: Saudi Gold And Its Authenticity
The Raphael Labs team was looking for an inexpensive preventative measure that didn’t need the infrastructure of a clinic or hospital for its administration.
The spray bottle should last 30 days, with the claimed effectiveness of five and six hours. Testing of the spray at the Queen Mary laboratory was conducted under the supervision of Professor Áine McKnight; professor of viral pathology at QMUL.
The spray’s effectiveness won’t be known until more exhaustive testing is conducted outside the laboratory, says Áine McKnight; professor of viral pathology at QMUL and advisor to Raphael Labs.
